Skip to main content
Clinical Trials/DRKS00027327
DRKS00027327
Completed
Not Applicable

Real-World observational study on the health situation (QoL) and the psychosocial well-being of patients with ulcerative colitis under filgotinib therapy in the long-term course

CED Service GmbH0 sites202 target enrollmentNovember 30, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
K51
Sponsor
CED Service GmbH
Enrollment
202
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 30, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with UC between the ages of 18 and 80 years at study inclusion.
  • Patients who are scheduled to receive new initiation therapy with filgotinib as determined by their treating physician.
  • Patients will be prescribed and receive therapy as part of the filgotinib subject information.
  • Optional additional scientific examination for motion profiles: availability of a personal smartphone.

Exclusion Criteria

  • A planned surgical intervention with inpatient hospital admission
  • A history of malignant disease (except for a Non\-Melanoma Skin Cancer \- NMSC)
  • Contraindications to therapy with filgotinib analogous to the SmPC

Outcomes

Primary Outcomes

Not specified

Similar Trials